Maravai LifeSciences Holdings, Inc. (MRVI)

NASDAQ: MRVI · IEX Real-Time Price · USD

7.61

-0.12 (-1.55%)

At close: Apr 18, 2024, 4:00 PM

7.46

-0.15 (-1.97%)

After-hours: Apr 18, 2024, 4:07 PM EDT

MRVI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	288.95	883	799.24	284.1	143.14	123.83
Revenue Growth (YoY)	-67.28%	10.48%	181.33%	98.48%	15.59%	-
Cost of Revenue	148.74	168.96	140.56	79.65	66.85	60.77
Gross Profit	140.2	714.04	658.68	204.45	76.29	63.07
Selling, General & Admin	151.39	129.26	100.06	94.25	48.35	41.19
Research & Development	17.28	18.37	15.22	9.3	3.63	4.5
Other Operating Expenses	6.47	0	-11.25	-19	0	0
Operating Expenses	175.14	147.63	104.03	84.55	51.98	45.69
Operating Income	-34.93	566.42	554.65	119.9	24.31	17.38
Interest Expense / Income	45.89	20.41	30.26	30.74	29.96	27.4
Other Expense / Income	-717.91	264.99	280.83	-2.69	-0.53	-5.97
Pretax Income	637.08	281.01	243.55	91.85	-5.12	-4.06
Income Tax	756.11	60.81	61.52	2.88	-0.65	0.42
Net Income	-119.03	220.21	182.04	88.97	-4.47	-4.47
Net Income Growth	-	20.97%	104.60%	-	-	-
Shares Outstanding (Basic)	132	132	115	10	254	254
Shares Outstanding (Diluted)	132	255	258	29	254	254
Shares Change	-48.33%	-0.96%	791.81%	-88.62%	0.00%	-
EPS (Basic)	-0.90	1.67	1.59	7.43	-0.03	-0.07
EPS (Diluted)	-0.90	1.67	1.56	2.36	-0.03	-0.07
EPS Growth	-	7.05%	-33.90%	-	-	-
Free Cash Flow	73.54	506.71	354.27	161.28	6.97	-3.8
Free Cash Flow Per Share	0.56	3.85	3.09	15.58	0.03	-0.01
Gross Margin	48.52%	80.87%	82.41%	71.96%	53.30%	50.93%
Operating Margin	-12.09%	64.15%	69.40%	42.20%	16.98%	14.03%
Profit Margin	-41.19%	24.94%	22.78%	31.32%	-3.12%	-3.61%
Free Cash Flow Margin	25.45%	57.39%	44.33%	56.77%	4.87%	-3.07%
Effective Tax Rate	118.68%	21.64%	25.26%	3.14%	-	-
EBITDA	731.76	339.53	307.36	148.43	48.92	45.69
EBITDA Margin	253.25%	38.45%	38.46%	52.25%	34.18%	36.90%
Depreciation & Amortization	48.78	38.1	33.54	25.84	24.08	22.35
EBIT	682.97	301.43	273.81	122.59	24.84	23.34
EBIT Margin	236.37%	34.14%	34.26%	43.15%	17.35%	18.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).